Clearbridge Investments, LLC Zai Lab LTD Transaction History

Clearbridge Investments, LLC

$119 Billion
Q4 2024

A detailed history of Clearbridge Investments, LLC transactions in Zai Lab LTD stock. As of the latest transaction made, Clearbridge Investments, LLC holds 1,862,842 shares of ZLAB stock, worth $62.9 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,862,842

Previous 873,178 113.34%

Holding current value

$62.9 Million

Previous $21.1 Million 131.46%

% of portfolio

0.04%

Previous 0.02%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$24.61 - $33.18 $24.4 Million - $32.8 Million	989,664 Added 113.34%	1,862,842 $48.8 Million
Q3 2024 Nov 12, 2024	BUY	$16.25 - $24.14 $1.31 Million - $1.94 Million	80,363 Added 10.14%	873,178 $21.1 Million
Q2 2024 Aug 14, 2024	SELL	$13.72 - $21.55 $271,162 - $425,914	-19,764 Reduced 2.43%	792,815 $13.7 Million
Q1 2024 May 13, 2024	SELL	$15.95 - $26.8 $172,594 - $290,002	-10,821 Reduced 1.31%	812,579 $13 Million
Q4 2023 Feb 09, 2024	BUY	$22.97 - $30.58 $11,760 - $15,656	512 Added 0.06%	823,400 $22.5 Million
Q3 2023 Nov 13, 2023	BUY	$22.72 - $31.49 $262,961 - $364,465	11,574 Added 1.43%	822,888 $20 Million
Q2 2023 Aug 11, 2023	BUY	$25.3 - $39.67 $382,055 - $599,056	15,101 Added 1.9%	811,314 $22.5 Million
Q1 2023 May 12, 2023	BUY	$30.21 - $48.1 $3.09 Million - $4.91 Million	102,142 Added 14.72%	796,213 $26.5 Million
Q4 2022 Feb 10, 2023	BUY	$22.28 - $38.71 $3.19 Million - $5.55 Million	143,256 Added 26.01%	694,071 $21.3 Million
Q3 2022 Nov 14, 2022	BUY	$34.2 - $51.69 $3.33 Million - $5.03 Million	97,260 Added 21.44%	550,815 $18.8 Million
Q2 2022 Aug 11, 2022	BUY	$23.14 - $49.68 $184,634 - $396,396	7,979 Added 1.79%	453,555 $15.7 Million
Q1 2022 May 13, 2022	BUY	$27.77 - $64.4 $815,493 - $1.89 Million	29,366 Added 7.06%	445,576 $19.6 Million
Q4 2021 Feb 11, 2022	BUY	$54.9 - $105.21 $8.33 Million - $16 Million	151,726 Added 57.37%	416,210 $26.2 Million
Q3 2021 Nov 12, 2021	SELL	$105.0 - $178.37 $12.4 Million - $21.1 Million	-118,094 Reduced 30.87%	264,484 $27.9 Million
Q2 2021 Aug 13, 2021	BUY	$125.11 - $180.0 $23.7 Million - $34.1 Million	189,192 Added 97.83%	382,578 $67.7 Million
Q1 2021 May 13, 2021	SELL	$126.27 - $191.71 $23.3 Million - $35.4 Million	-184,727 Reduced 48.85%	193,386 $25.8 Million
Q4 2020 Feb 10, 2021	SELL	$81.94 - $135.34 $2.6 Million - $4.3 Million	-31,788 Reduced 7.76%	378,113 $51.2 Million
Q3 2020 Nov 12, 2020	BUY	$73.3 - $89.48 $490,816 - $599,158	6,696 Added 1.66%	409,901 $34.1 Million
Q2 2020 Aug 14, 2020	BUY	$48.82 - $82.53 $1.65 Million - $2.78 Million	33,699 Added 9.12%	403,205 $33.1 Million
Q1 2020 May 15, 2020	BUY	$39.1 - $62.9 $2.49 Million - $4 Million	63,651 Added 20.81%	369,506 $19 Million
Q4 2019 Feb 14, 2020	BUY	$29.79 - $43.06 $2.58 Million - $3.72 Million	86,494 Added 39.43%	305,855 $13 Million
Q3 2019 Nov 14, 2019	BUY	$30.47 - $37.65 $359,789 - $444,571	11,808 Added 5.69%	219,361 $7.1 Million
Q2 2019 Aug 14, 2019	BUY	$25.73 - $35.79 $2.95 Million - $4.11 Million	114,740 Added 123.62%	207,553 $0
Q1 2019 May 15, 2019	BUY	$21.71 - $31.54 $487,324 - $707,978	22,447 Added 31.9%	92,813 $2.74 Million
Q4 2018 Feb 14, 2019	BUY	$14.95 - $24.72 $223,786 - $370,033	14,969 Added 27.02%	70,366 $1.63 Million
Q3 2018 Nov 14, 2018	BUY	$17.8 - $25.35 $872,200 - $1.24 Million	49,000 Added 765.98%	55,397 $1.08 Million
Q2 2018 Aug 14, 2018	BUY	$18.0 - $25.01 $86,580 - $120,298	4,810 Added 303.09%	6,397 $149,000
Q1 2018 May 15, 2018	BUY	$20.05 - $26.96 $31,819 - $42,785	1,587 New	1,587 $34,000

Others Institutions Holding ZLAB

# of Institutions

146

Shares Held

53M

Call Options Held

103K

Put Options Held

439K

View Full List

About Zai Lab Ltd

Ticker ZLAB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,908,704
Market Cap $3.31B
Description
Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. The company's commercial products include Zejula, a once-daily small-molecule poly polymerase 1/2 inhibitor; Optune, a device that delivers tumor treating fields; NUZYRA f...

More about ZLAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Clearbridge Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clearbridge Investments, LLC with notifications on news.

Account

Clearbridge Investments, LLC Zai Lab LTD Transaction History